A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)

Clinical trial NCT01215188 · COMPLETED

Trial details

NCT number: NCT01215188
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2010-10-14
Primary completion: 2012-07-31
Enrollment: 1152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.